| A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol | |
| Qiu, Shuang-Jian; Zhou, Zhong-Guo; Shen, Feng; Li, Ai-Jun; Chen, Min-Shan; Ying, Min-Gang; Chen, Zhong; Zhang, Yi-Xin; Sun, Hui-Chuan; Fan, Jia | |
| 刊名 | EXPERT OPINION ON BIOLOGICAL THERAPY
 |
| 2015 | |
| 卷号 | 15 |
| 关键词 | hepatitis B virus hepatocellular carcinoma immune regulator thymalfasin (thymosin-alpha 1/Tal) |
| ISSN号 | 1471-2598 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4874672 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Qiu, Shuang-Jian,Zhou, Zhong-Guo,Shen, Feng,et al. A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol[J]. EXPERT OPINION ON BIOLOGICAL THERAPY,2015,15. |
| APA | Qiu, Shuang-Jian.,Zhou, Zhong-Guo.,Shen, Feng.,Li, Ai-Jun.,Chen, Min-Shan.,...&Fan, Jia.(2015).A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol.EXPERT OPINION ON BIOLOGICAL THERAPY,15. |
| MLA | Qiu, Shuang-Jian,et al."A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol".EXPERT OPINION ON BIOLOGICAL THERAPY 15(2015). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论